Skip to main content
PLOS One logoLink to PLOS One
. 2020 Sep 15;15(9):e0238092. doi: 10.1371/journal.pone.0238092

One-pot three component synthesis of substituted dihydropyrimidinones using fruit juices as biocatalyst and their biological studies

Susheel Gulati 1,*,#, Rajvir Singh 1,#, Ram Prakash 2,#, Suman Sangwan 1,#
Editor: A Ganesan3
PMCID: PMC7491738  PMID: 32931491

Abstract

New and facile one-pot three component approach for the synthesis of substituted dihydropyrimidinones derivatives (4a-4h) from reaction of equimolar substituted aldehydes (1a-1h), methyl acetoacetate (2a) and urea (3a) in presence of nature derived catalyst viz. Cocos nucifera L. juice, Solanum lycopersicum L. juice and Citrus limetta juice, commonly known as coconut juice, tomato juice and musambi juice respectively, at room temperature has been carried out. All synthesized compounds were evaluated for in vitro herbicidal activity against Raphanus sativus L. (Radish seeds). The compounds (4a-4h) were also screened for their antifungal activity against Rhizoctonia solani and Colletotrichum gloeosporioides by poisoned food techniques method. Antibacterial activity was also studied against Erwinia cartovora and Xanthomonas citri by inhibition zone method. From activity data, it was found that compounds 4g and 4d were most active against Raphanus sativus L. (root) and Raphanus sativus L. (shoot) respectively. Compounds 4f and 4c was found most active against Rhizoctonia solani and Colletotrichum gloeosporioides fungus respectively at highest concentration. Compound 4g has shown maximum inhibition zone i.e. 1.00–5.50 mm against Erwinia cartovora at 2000 μg/mL concentration. Maximum Xanthomonas citrii growth was inhibited by compounds 4f showing inhibition zone 4.00–12.00 mm at highest concentration. Short reaction time, high yields, mild reaction condition and simple work-up are some merits of present methodology.

Introduction

Dihyropyrimidinones and its derivatives are found in a large family of natural products with wide biological activities, due to which they become important class of heterocyclic compounds. They generally possess therapeutic and pharmacological properties [1] and several derivatives of dihydropyrimidinone acts as calcium channel modulators [2], Ca-antagonists and vasodilative and antihypertensive [3]. In 1893, Biginelli reported the synthesis of dihyropyrimidinones, which is one-pot three component reaction between an substituted aldehydes, β-ketoester and urea. The major drawbacks of this procedure are lower yields and longer reaction time [4]. Therefore, we need to perform a very mild, simple, cost-effective, commercially beneficial and eco-friendly procedure for synthesis of dihydropyrimidinone derivatives for the academia and pharmaceutical industries [5]. Recently an efficient and facile green method has been developed for synthesizing substituted dihydropyrimidinones via Biginelli reaction at room temperature in presence of fruit juices viz amla, orange and lime juice [6]. Fruit juice is also acts as natural acids which were used as biocatalyst in organic synthesis. Now a day’s fruit juice used in organic synthesis as homogeneous catalysts for various selective transformations of simple and complex molecules. The growing interest in fruit juice is mainly because of its biocatalysts, eco-friendly nature, non-toxic, non-hazardous and cost effective [7]. Therefore, in this paper we reported one-pot three components clean and facile synthesis of dihydropyrimidinone derivative in presence of fruit juices viz. Cocos nucifera L., Solanum lycopersicum L., Citrus limetta respectively. Some biologically and pharmacologically active dihydropyrimidinones derivatives are shown in Fig 1.

Fig 1. Some medicinally important substituted dihyropyrimidinones.

Fig 1

Materials and methods

All the chemicals were purchased from CDH (Central Drug House), SRL (Sisco Research Laboratory) and Sigma-Aldrich. Reaction were performed in oven-dried glassware and monitored by thin layer chromatography (TLC) silica gel plates using ethylacetate in hexane and other solvents combinations as the mobile phase. Melting points were determined in open capillaries on a Ganson electric melting point apparatus and are uncorrected. The 1HNMR spectra were recorded in CDCl3 or DMSO-d6 using tetra methyl silane (TMS) as internal reference on “Brucker Ac 400 F“(400MHz) nuclear magnetic resonance spectrometer. The chemical shifts values are quoted in delta (parts per million, ppm). Infrared spectra (4000–350 cm-1) of the synthesized compounds were recorded in KBr pellets on Perkin Elmer FTIR-R2X spectrophotometer and frequency is expressed in cm-1.

Biological studies

Herbicidal activity

Solutions of 50 μg/ mL, 100 μg/ mL, 150 μg/ mL and 200 μg/ mL of the test compounds in DMSO were prepared. Agar powder (5g) was put into boiling distilled water (1L) until it dissolved, and then cooled down to 40–50°C. The solution (2mL) containing test compounds and melting agar (18mL) was mixed and this mixture was added to a Petridish with 4.5 cm diameter. The agar plate without test compound was used as an untreated control. Then 15 seeds of Raphanus Sativus L. (Radish) were put on the surface of the agar plate. The Petridishes were covered with glass lids, and the cultivation conditions were kept at 25±1°C and 12 hours in light and 12 hours in dark alternating for seven days. Seven days later, the root lengths and shoot lengths of Raphanus sativus L. were measured. The growth inhibitory rate related to untreated control was determined by given formula [8].

%Inhibition=ControlTreatedControl×100

Antifungal activity

All synthesized compounds (4a-4h) were tested for their antifungal activity against Rhizoctonia solani and Colletotrichum gloeosporioides respectively. Fungal species were grown in laboratory on Potato dextrose agar (PDA) media. The antifungal activity was determined by poisoned food technique method [9]. The required amount of synthesized compounds dissolved in 1 mL of DMSO was incorporated aseptically into 99 mL aliquots of sterilized potato dextrose agar cooled at 45°C after brief shaking. Each lot of medium was poured into Petri dishes and allowed to solidify. DMSO was used as negative control. Each dish was inoculated centrally with a 5 mm mycelial disc cut from the periphery of 2–3 days old fungal colonies. Inoculated Petri plates were incubated in the dark 25±2°C for 48–72 h and colony diameters were measured periodically till the control dishes were nearly completely covered with fungus growth. All observations were made in triplicate. The degree of inhibition of growth was calculated from the mean differences between treatments and the control as percentage of latter by using the formula.

%Inhibition=ControlTreatedControl×100

Control = mycelial growth in control dish

Treated = mycelial growth in treated dish

Antibacterial activity

Bacterial species Erwinia cartovora and Xanthomonas citri were grown on Luria-Bertani medium in laboratory. Antibacterial activity was evaluating using inhibition zone method [10]. 250, 500, 1000 and 2000 μg/ mL concentrations of synthesized compounds were prepared from the stock solution by taking appropriate amount and diluting with DMSO. DMSO was used as negative control. The circular paper discs of 10 mm diameter were prepared from Whatman’s Filter paper No. 1. The disc were kept in Petri plate and autoclaved at 15 lbs pressure 20 minutes. Two paper discs were used for each concentration of the synthesized compounds. The excess of solution absorbed by paper discs was removed by holding them vertically by sterile forecep. Such soaked discs were transferred aseptically to Petri plates containing media and bacterial suspension spread over the surface. The Petri plates were kept in an incubator at 25±2°C overnight and then examined for inhibition zone at these different concentrations of compounds. The experiment was performed in triplicate and activity was determined on the basis of inhibition zone (in mm).

Statistical analysis

The experiments were performed in triplicates for each treatment and the mean value were recorded and expressed as mean ± S.D. The descriptive statistics in form of box-and-whisker diagram were also presented in this paper. The spacing between the different parts of the box indicates the degree of dispersion and skewness in the data.

Preparation of biocatalyst

Extraction of Cocos nucifera L. juice. The coconut juice was obtained by perforating the fruit with a knife. The coconut juice was filtered using filter paper whatman no 1 for the elimination of residues to get clear juice which was used as a catalyst [11].

Preparation of Solanum lycopersicum L. juice. Fresh tomatoes were purchased from the local market. Then washed thoroughly under running tap water followed by rinsing thrice with double distilled water. Tomatoes were squeezed and juice were strained initially through a muslin cloth then passed through Whatman filter paper No. 1 [12].

Preparation of Citrus limetta juice. First of all wash the sweet limes and pat them dry. Cut them into two halves. Then using a citrus juice squeezer, extract the juice. Then the juice was filtered through cotton and then through whatman filter paper no 1 to remove solid material and to get clear juice which as used as a catalyst [13].

General procedure for the synthesis of substituted dihydropyrimidinones derivatives (4a-4h)

By Cocos nucifera L. juice (Method A). The mixture of 20 mmol of substituted aldehydes (1a-1h), 20 mmol of methyl acetoacetate (2a), 20 mmol of urea (3a) and 2.5 mL of Cocos nucifera L. juice was stirring at room temperature. The completion of reaction was monitored by TLC. Then the reaction mixture was filtered, washed with water and pure yellow crystalline solid (4a-4h) recovered by recrystallized with methanol. All synthesized compounds were confirmed by FTIR and NMR and its melting point.

By Solanum lycopersicum L. juice (Method B). A mixture of substituted aldehydes (20 mmol) (1a-1h), methyl acetoacetate (20 mmol) (2a), urea (20 mmol) (3a) and Solanum lycopersicum L. juice (10 mL) was taken in round-bottom flask and stirring at room temperature. The progress of reaction was monitored using thin layer chromatography. Then the reaction mixture was filtered, washed with water and pure yellow crystalline solid (4a-4h) recovered by recrystallized with methanol. All synthesized compounds were confirmed by FTIR and NMR and its melting point.

By Citrus limetta juice (Method C). In 50 mL round bottom flask, substituted aldehydes (20 mmol) (1a-1h), methyl acetoacetate (20 mmol) (2a), urea (20 mmol) (3a) and Citrus limetta juice (10 mL) was stirred till the completion of reaction as indicated by thin layer chromatography. Then the reaction mixture was filtered, washed with water and pure yellow crystalline solid (4a-4h) recovered by recrystallized with methanol. All synthesized compounds were confirmed by FTIR and NMR and its melting point.

All the dihydropyrimidinone derivatives (4a-4h) were prepared according to Method A, B and C.

Results and discussion

We reported the synthesis of substituted dihydropyrimidinones (4a-4h) by one-pot multicomponent reaction between equimolar substituted aldehydes (1a-1h) viz. 2-Hydroxybenzaldehyde (1a), 4-Methoxybenzaldehyde (1b), 3,4-Dimethoxybenzaldehyde (1c), 4-Chlorobenzaldehyde (1d), 4-Bromobenzaldehyde (1e), 3-Hydroxybenzaldehyde (1f), 2-Chlorobenzaldehyde (1g) and 4-Methylbenzaldehyde (1h) methyl acetoacetate (2a) and urea (3a) in presence of green catalyst viz. Cocos nucifera L. juice, Solanum lycopersicum L. juice and Citrus limetta juice at room temperature (Scheme 1).

Scheme 1. Synthesis of substituted dihyropyrimidinones (4a-4h).

Scheme 1

The reaction conditions were optimized by performing the reaction between 4-Hydroxy-3-methoxybenzaldehyde (20 mmol), methyl acetoacetate (20 mmol) and urea (20 mmol) in presence of catalyst viz. Cocos nucifera L. juice, Solanum lycopersicum L. juice and Citrus limetta juice at room temperature. Initially, the reaction was attempted between 4-Hydroxy-3-methoxybenzaldehyde (20 mmol), methyl acetoacetate (20 mmol) and urea (20 mmol) in presence of Cocos nucifera L. juice at room temperature. It was found that excellent yield (86%) of product was obtained when amount of Cocos nucifera L. juice was 2.5 mL and reaction time was also reduced (Table 1, Entry 4). These results indicated that 2.5 mL of Cocos nucifera L. juice gives high yield of product over the completion of the reaction. Further the reaction was also optimized in presence of Solanum lycopersicum L. juice and Citrus limetta juice respectively. When the concentration of Solanum lycopersicum L. juice in the reaction mixture was 10.0 mL than yield of reaction was maximum (91%) and reaction completed in 5h (Table 2, Entry 4). Hence 10.0 mL of Solanum lycopersicum L. juice under aqueous conditions at room temperature is the optimal condition for this reaction. The same reaction was also screened under aqueous conditions at room temperature in presence of Citrus limetta juice and maximum yield 93% (Table 2, Entry 4) was obtained when the amount of Citrus limetta juice was 10.0 mL in reaction mixture. The physical data of this study are presented in Table 3. After completion of the reaction, the solid products was collected by simple filtration and then recrystallized in methanol to afford pure dihydropyrimidinone derivatives (4a-4h). The structure of synthesized compounds was confirmed by 1HNMR, FTIR analysis as well as comparison of their melting points with those of reported compounds. The comparison of activity of different catalysts with respect to time and yield of reaction as shown in Table 4. All synthesized substituted dihydropyrimidinones derivatives (4a-4h) were shown in Fig 2. From spectral study it was found that compound viz. Methyl 4-(2-hydroxyphenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4a) showed 1H NMR spectrum in DMSO-d6, displayed a singlet at 1.75 δ integrating for three proton of methyl group, singlet at 3.71 δ integrating for three proton of COOCH3 group, singlet at 4.51 δ integrating for one proton of OH group, multiplet at 6.73–7.19 δ integrating for proton of aryl group, singlet at 7.46 δ integrating for one proton of NH group, singlet at 7.69 δ integrating for one proton of NH group and melting point 198–200°C. The compound viz. Methyl 6-(4-methoxyphenyl)-4-methyl-2-oxo-1, 2-dihydropyrimidine-5-carboxylate (4b) showed 1H NMR spectrum in DMSO-d6, displayed a singlet at 2.25 δ integrating for three proton of methyl group, singlet at 3.72 δ integrating for three proton of aryl methoxy group, singlet at 3.51 δ integrating for three proton of COOCH3 group, multiplet at 6.57–7.66 δ integrating for proton of aryl group, singlet at 5.11 δ integrating for one proton of NH group, singlet at 9.16 δ integrating for one proton of NH group and melting point 204–205°C. The compound viz. Methyl 4-(3,4-dimethoxyphenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4c) showed 1H NMR spectrum in DMSO-d6, displayed a singlet at 2.51 δ integrating for three proton of methyl group, singlet at 3.82 δ integrating for three proton of aryl methoxy group, singlet at 3.86 δ integrating for three proton of aryl methoxy group, multiplet at 7.13–7.55 δ integrating for proton of aryl group, singlet at 5.48 δ integrating for one proton of NH group, singlet at 9.83 δ integrating for one proton of NH group and melting point 198°C. The compound viz. Methyl 6-(4-chlorophenyl)-4-methyl-2-oxo-1,2-dihydropyrimidine-5-carboxylate (4d) displayed IR absorptions at 3415.3, 3325.7, 1680.5, 1591.5 and 761.0 cm-1 indicating the presence of NH, NH, C = O, C = C aromatic and C-Cl respectively. The compound viz. Methyl 6-(4-bromophenyl)-4-methyl-2-oxo-1,2-dihydropyrimidine-5-carboxylate (4e) displayed IR absorptions at 3436.6, 3307.5, 1696.2, 1587.8 and 811.7 cm-1 indicating the presence of NH, NH, C = O, C = C aromatic and C-Br respectively and melting point 205°C. The compound viz. Methyl6-(3-hydroxyphenyl)-4-methyl-2-oxo-1,2-dihydropyrimidine-5-carboxylate (4f) displayed IR absorptions at 3227.7, 3106.4, 3372.4, 1714.0 and 1487.9 cm-1 indicating the presence of NH, NH, OH, C = O and C = C aromatic respectively and melting point 201°C. The compound viz. Methyl 6-(2-chlorophenyl)-4-methyl-2-oxo-1,2-dihydropyrimidine-5-carboxylate (4g) showed 1H NMR spectrum in DMSO-d6, displayed a singlet at 2.31 δ integrating for three proton of methyl group, singlet at 3.46 δ integrating for three proton of COOCH3 group, multiplet at 7.20–7.36 δ integrating for proton of aryl group, singlet at 5.65 δ integrating for one proton of NH group, singlet at 9.27 δ integrating for one proton of NH group and melting point 202–204°C. The compound viz. Methyl 4-methyl-2-oxo-6-(p-tolyl)-1,2-dihydropyrimidine-5-carboxylate (4h) displayed IR absorptions at 3484.4, 3335.7, 1740.5 and 1651.7 cm-1 indicating the presence of NH, NH, C = O and C = C aromatic respectively and melting point 208°C. We found that Cocos nucifera L. juice, Solanum lycopersicum L. juice and Citrus limetta juice gives the best catalytic activity in terms of product yield, reaction condition and reaction time compared to other catalyst in literature viz. p-TSA, ZnCl2, Zn(BF)4, Y(OAC)3, Mg(NO3)2, CaCl2, InBr3, Pb(NO3)2, P2O5 and Citric acid. The catalyst used in present study is nature derived, easily available and cost effective which makes this procedure is eco-friendly. In summary, we have reported a facile one-pot three component synthesis of substituted dihydropyrimidinones derivatives by condensation of substituted aldehyde, methyl acetoacetate and urea at room temperature in presence of Cocos nucifera L. juice, Solanum lycopersicum L. juice and Citrus limetta juice in excellent yields. The current procedure offers many advantages such as simple and efficient catalytic system, simple work-up, no use of hazardous solvents, cheap and products are obtained in good to excellent yields. Moreover, all products were obtained through simple filtration with no need for column chromatography, which reduces the waste as well as environmental pollution. We also conclude that current protocol will provide great utility in the synthesis of other heterocyclic compounds in the near future. The proposed mechanism for the formation of substituted dihydropyrimidinones is shown in Scheme 2.

Table 1. Model reaction using Cocos nucifera L. juice as catalyst.

Entry Catalyst Concentration (mL) Method A
Time (min) Yield (%)
1 1.0 60 69
2 1.5 30 71
3 2.0 20 75
4 2.5 10 86

Table 2. Model reaction using Solanum lycopersicum L. juice and Citrus limetta juice as catalyst.

Entry Catalyst Concentration (mL) Method B Method C
Time (h) Yield (%) Time (h) Yield (%)
1 4.0 14 11 12 62
2 6.0 12 76 9 85
3 8.0 9 90 6 91
4 10.0 5 91 4.5 93

Table 3. Physical data of substituted dihyropyrimidinones (4a-4h).

Entry Product R R1 R2 Method A Method B Method C mp ºC lit mpref
Time (min) Yield (%) Time (h) Yield (%) Time (h) Yield
(%)
1 [4b] [2-OHPh] OCH3 CH3 10 81 8 86 5 78 198–200, 200–202 [15]
2 [4a] [4-OCH3Ph] OCH3 CH3 10 82 8 87 8 81 204–205, 201–203 [16]
3 [4c] [3,4-OCH3Ph] OCH3 CH3 10 84 6 80 4 82 198
4 [4d] [4-ClPh] OCH3 CH3 10 90 2 86 4 75 180–182, 182–184 [17]
5 [4e] [4-BrPh] OCH3 CH3 10 85 2 88 4 80 205
6 [4f] [3-OHPh] OCH3 CH3 10 78 6 90 5 87 201
7 [4g] [2-ClPh] OCH3 CH3 30 80 4 83 5 92 202–204, 205–206 [18]
8 [4h] [4-CH3Ph] OCH3 CH3 60 87 4 80 4 81 208

Table 4. Comparison for different catalysts used for synthesis of dihyropyrimidinones (4a-4h).

S.No Catalyst Reaction condition Time (h) Yield (%) References
1 p-TSA Refluxed in EtOH 1.0 90 [19]
2 ZnCl2 MW Irradiation 30 sec 94 [20]
3 Zn(BF)4 Stirring at RT 4.0 71 [21]
4 Y(OAC)3 115°C 4.5 89 [22]
5 Mg(NO3)2 Refluxed 45 min 90 [23]
6 CaCl2 Refluxed in EtOH 2.0 98 [24]
7 InBr3 Refluxed in EtOH 7.0 97 [25]
8 Pb(NO3)2 Refluxed in CH3CN 3.0 89 [26]
9 P2O5 Refluxed at 100°C 1.5 94 [27]
10 Citric acid 80°C 1.0 79 [28]
11 Cocos nucifera L. juice RT 10 min 86 Present work
12 Solanum lycopersicum L. juice RT 5.0 91 Present work
13 Citrus limetta juice RT 4.5 93 Present work

Fig 2. Substituted dihydropyrimidinones derivatives (4a-4h).

Fig 2

Scheme 2. Proposed mechanism for formation of substituted dihyropyrimidinones (4a-4h).

Scheme 2

The first mechanism via the iminium route involves condensation between aldehyde and urea to form iminium intermediate (D), which undergoes nucleophillic addition with a β-keto ester leading to DHPMs. The second mechanism via enamine route (E) involves condensation reaction between urea and β-keto ester form protonated enamine intermediate, which reacts with aldehyde to give DHPMs. The third mechanism involves Knoevenagel condensation reaction (F) between aldehyde and β-keto ester results in the formation of carbenium ion intermediate, which further react with urea to give DHPMs [14]. It was also found that iminium mechanism is the most favourable route, both kinetically and thermodynamically to form DHPMs derivatives. Thus both experimental and theoretical results support the mechanism via iminium route as most plausible one for Biginelli reaction.

Herbicidal activity

All compounds (4a-4h) were tested for herbicidal activity against Raphanus sativus L. at 200, 150, 100 and 50 μg/mL concentrations as shown in Table 5. Results were shown in the form of primary screening. All compounds were diluted to 1000 μg/mL concentration as a stock solution. Herbicidal activities of compounds were evaluated against Raphanus sativus L. by inhibitory effect of compounds on the growth of weed roots and shoots. The percentage of inhibition growth was calculated from mean differences between treated and control. From the herbicidal activity results, we observed that compound 4g was exhibited maximum percentage growth inhibition i.e. 93.33 against Raphanus sativus L. (root) whereas compound 4d was exhibited maximum percentage growth inhibition i.e. 87.50 against Raphanus sativus L. (shoot) respectively at 200 μg/mL concentrations. The compounds 4g and 4d showed broad-spectrum herbicidal activity because of presence of chloro substitution at phenyl ring. The herbicidal activity of compounds is given in Fig 3. The box plot and graphical representation of herbicidal activity of all compounds against Raphanus sativus L. were shown in Figs 47.

Table 5. Herbicidal activity of substituted dihydropyrimidinones (4a-4h).

Compounds Growth Inhibition (%)
Root Shoot
50 (μg/mL) 100 (μg/mL) 150 (μg/mL) 200 (μg/mL) 50 (μg/mL) 100 (μg/mL) 150 (μg/mL) 200 (μg/mL)
4a 25.00 ± 0.86 50.00 ± 0.83 66.60 ± 1.05 83.33 ± 1.26 47.50 ± 0.46 56.25 ± 0.85 71.25 ± 1.00 81.25 ± 1.07
4b 33.33 ± 1.00 50.00 ± 2.00 75.00 ± 0.99 91.66 ± 1.07 56.25 ± 0.72 68.75 ± 0.74 81.20 ± 1.01 86.25 ± 0.56
4c 30.20 ± 1.02 49.36 ± 1.09 74.89 ± 1.24 92.36 ± 0.99 54.27 ± 0.90 68.12 ± 1.15 78.78 ± 0.58 87.36 ± 0.93
4d 16.60 ± 1.00 33.33 ± 0.94 58.33 ± 1.34 83.33 ± 0.07 37.50 ± 0.99 52.50 ± 1.21 68.75 ± 0.74 87.50 ± 1.07
4e 18.67 ± 0.52 37.38 ± 0.80 59.64 ± 1.27 87.52 ± 0.53 16.66 ± 1.80 35.48 ± 0.68 56.97 ± 0.76 81.87 ± 1.08
4f 38.72 ± 0.90 53.16 ± 0.99 70.48 ± 1.00 89.38 ± 0.93 36.78 ± 0.67 48.18 ± 0.85 66.66 ± 0.74 84.78 ± 1.15
4g 66.60 ± 0.53 76.60 ± 1.00 86.60 ± 0.47 93.33 ± 1.46 47.69 ± 0.78 61.50 ± 0.85 72.30 ± 1.07 84.61 ± 1.06
4h 50.00 ± 0.82 66.60 ± 1.12 80.00 ± 0.84 90.00 ± 1.26 38.46 ± 1.49 53.80 ± 1.00 66.15 ± 0.86 83.07 ± 1.71

All values are mean ± S.D.

Fig 3. Herbicidal activity of substituted dihydropyrimidinones (4a-4h).

Fig 3

Fig 4. Box plot of substituted dihyropyrimidinones (4a-4h) against Raphanus sativus L. (root).

Fig 4

Fig 7. Herbicidal activity of substituted dihyropyrimidinones (4a-4h) against Raphanus sativus L. (shoot).

Fig 7

Fig 5. Herbicidal activity of substituted dihyropyrimidinones (4a-4h) against Raphanus sativus L. (root).

Fig 5

Fig 6. Box plot of substituted dihyropyrimidinones (4a-4h) against Raphanus sativus L. (shoot).

Fig 6

Antimicrobial evaluation

Antifungal activity

All synthesized compounds (4a-4h) were screened for their antifungal activity against 2 fungal strains viz. Rhizoctonia solani and Colletotrichum gloeosporioides by poisoned food technique method. DMSO was used as negative control against fungal strains. The result of antibacterial activity of tested compounds is shown in Table 6. Most of synthesized compounds possess a moderate to good activity against R. solani and C. gloeosporioides respectively. Compounds (4a) and (4b) was found active against Rhizoctonia solani fungus at 250, 500, 1000 and 2000 μg/mL concentrations showing percentage growth inhibition 61.53, 71.15, 80.76, 86.53% and 41.35, 62.56, 78.13, 89.38% respectively. Compounds (4c), (4d), (4e) and (4f), (4g), (4h) has been also shown growth inhibition 50.87, 69.99, 80.00, 91.13%, 40.38, 65.38, 80.76, 90.38%, 35.70, 54.68, 67.30, 79.89% and 55.50, 70.50, 80.98, 92.00%, 48.27, 65.51, 75.86, 82.75%, 60.78, 70.58, 82.35, 90.19% respectively against Rhizoctonia solani at different concentrations 250, 500, 1000 and 2000 μg/mL. Compounds (4a) and (4b) was found active against Colletotrichum gloeosporioides fungus at 250, 500, 1000 and 2000 μg/mL concentrations showing percentage growth inhibition 37.89, 53.80, 78.18, 89.78% and 35.63, 58.45, 74.89, 87.12% respectively. Compounds (4c), (4d), (4f) and (4g) has been also shown growth inhibition 49.90, 67.70, 79.45, 91.58%, 31.25, 48.70, 67.93, 82.56%, 33.30, 52.78, 77.80, 88.45% and 29.96, 49.00, 68.12, 83.59% respectively against Colletotrichum gloeosporioides fungus at different concentrations 250, 500, 1000 and 2000 μg/mL. Compound (4e) has shown no growth inhibition at all concentrations. Compound (4h) has shown no growth inhibition at lower concentrations. Compound (4h) exhibited 40.50 and 68.54% growth inhibition against Colletotrichum gloeosporioides fungus at 1000 μg/mL and 2000 μg/mL concentration respectively. From antifungal activity results, we concluded that compound (4f) was shown to most promising against R. solani and compound (4c) was shown to most promising against C. gloeosporioides. This result may be due to substitution of hydroxy and methoxy groups on phenyl ring. The box plot and graphical representation of antifungal activity of all compounds against Rhizoctonia solani and Colletotrichum gloeosporioides were shown in Figs 811.

Table 6. Antifungal activity of substituted dihydropyrimidinones (4a-4h).

Compounds Growth inhibition (%)
Fungi
Rhizoctonia solani (conc.) μg/mL Colletotrichum gloeosporioides (conc.) μg/mL
250 500 1000 2000 250 500 1000 2000
4a 61.53 ± 0.90 71.15 ± 1.03 80.76 ± 2.01 86.53 ± 1.08 37.89 ± 1.16 53.80 ± 0.77 78.18 ± 0.16 89.78 ± 1.09
4b 41.35 ± 0.89 62.56 ± 0.72 78.13 ± 0.70 89.38 ± 1.04 35.63 ± 1.19 58.45 ± 1.16 74.89 ± 1.10 87.12 ± 0.96
4c 50.87 ± 1.04 69.99 ± 0.78 80.00 ± 2.67 91.13 ± 1.95 49.90 ± 1.05 67.70 ± 0.50 79.45 ± 1.10 91.58 ± 1.06
4d 40.38 ± 1.53 65.38 ± 1.02 80.76 ± 1.76 90.38 ± 1.42 31.25 ± 1.00 48.70 ± 1.26 67.93 ± 0.98 82.56 ± 0.61
4e 35.70 ± 1.00 54.68 ± 0.37 67.30 ± 1.61 79.89 ± 2.26 a a a a
4f 55.50 ± 1.64 70.50 ± 2.45 80.98 ± 2.26 92.00 ± 1.02 33.30 ± 1.59 52.78 ± 1.39 77.80 ± 0.99 88.45 ± 0.61
4g 48.27 ± 1.92 65.51 ± 1.62 75.86 ± 2.41 82.75 ± 1.37 29.96 ± 1.36 49.00 ± 0.71 68.12 ± 0.92 83.59 ± 0.45
4h 60.78 ± 1.84 70.58 ± 1.61 82.35 ± 1.06 90.19 ± 0.64 a a 40.50 ± 1.70 68.54 ± 0.91

All values are mean ± S.D.

a: No Growth inhibition

Fig 8. Box plot of substituted dihyropyrimidinones (4a-4h) against Rhizoctonia solani.

Fig 8

Fig 11. Antifungal activity of substituted dihyropyrimidinones (4a-4h) against Colletotrichum gloeosporioides.

Fig 11

Fig 9. Antifungal activity of substituted dihyropyrimidinones (4a-4h) against Rhizoctonia solani.

Fig 9

Fig 10. Box plot of substituted dihyropyrimidinones (4a-4h) against Colletotrichum gloeosporioides.

Fig 10

Antibacterial activity

The optimistic antifungal activity of synthesized compounds (4a-4h) has influenced authors to test further for antibacterial activity. All synthesized compounds (4a-4h) were tested for their in vitro antibacterial activity against two bacterial strains Erwinia cartovora and Xanthomonas citri by inhibition zone method using DMSO as negative control. The results of antibacterial activity of synthesized compounds were shown in Table 7. No inhibition zone was shown by compounds (4a) and (4d) at all the concentration against Erwinia cartovora. Compounds (4b) and (4c) was found active against Erwinia cartovora at 250, 500, 1000 and 2000 μg/mL concentrations showing inhibition zone 0.90 mm, 1.50 mm, 2.00 mm, 3.00 mm and 1.70 mm, 2.80 mm, 4.00 mm, 5.00 mm respectively. Compound (4e) has shown no inhibition zone at lower concentrations. Compound (4e) exhibited 0.70 mm and 1.10 mm inhibition zone against Erwinia cartovora at 1000 and 2000 μg/mL concentration respectively. Compounds (4f), (4g) and (4h) was found active against Erwinia cartovora at 250, 500, 1000 and 2000 μg/mL concentrations showing inhibition zone 1.00 mm, 2.00 mm, 3.00 mm, 5.00 mm, 1.00 mm, 2.50 mm, 3.00 mm, 5.50 mm and 1.00 mm, 2.00 mm, 3.00 mm, 4.00 mm respectively. Compounds (4a) and (4d) have shown no inhibition zone at all the concentrations against Xanthomonas citri. Compounds (4b) and (4c) was found active against Xanthomonas citri at 250, 500, 1000 and 2000 μg/mL concentrations showing inhibition zone 1.40 mm, 2.10 mm, 3.40 mm, 4.10 mm and 0.90 mm, 1.50 mm, 1.70 mm, 2.20 mm respectively. Compounds (4e) and (4f) was found active against Xanthomonas citri at 250, 500, 1000 and 2000 μg/mL concentrations showing inhibition zone 3.00 mm, 5.50 mm, 7.60 mm, 9.90 mm and 4.00 mm, 7.10 mm, 9.50 mm, 12.00 mm respectively. Compound (4g) has shown no inhibition zone at lower concentrations. Compound (4g) exhibited 1.10 mm and 2.00 mm inhibition zone against Xanthomonas citri at 1000 and 2000 μg/mL concentration respectively. Compounds (4h) was found active against Xanthomonas citri at 250, 500, 1000 and 2000 μg/mL concentrations showing inhibition zone 1.10 mm, 1.90 mm, 3.00 mm, 5.00 mm respectively. Maximum Erwinia cartovora growth was inhibited by compounds (4g) showing inhibition zone 1.00–5.50 mm. Maximum Xanthomonas citri growth was inhibited by compounds (4f) showing inhibition zone 4.00–12.00 mm. This inhibition may be due to presence of chloro and hydroxy substitution on phenyl groups. The box plot and graphical representation of antibacterial activity of all compounds against Erwinia cartovora and Xanthomonas citri were shown in Figs 1215.

Table 7. Antibacterial activity of substituted dihydropyrimidinones (4a-4h).

Compounds Inhibition Zone (mm)
Bacteria
Erwinia cartovora (conc.) μg/mL Xanthomonas citri (conc.) μg/mL
250 500 1000 2000 250 500 1000 2000
4a a a a a a a a a
4b 0.90 ± 0.07 1.50 ± 0.10 2.00 ± 0.30 3.00 ± 0.40 1.40 ± 0.20 2.10 ± 0.18 3.40 ± 0.20 4.10 ± 0.45
4c 1.70 ± 0.30 2.80 ± 0.35 4.00 ± 0.41 5.00 ± 0.45 0.90 ± 0.07 1.50 ± 0.28 1.70 ± 0.15 2.20 ± 0.47
4d a a a a a a a a
4e a a 0.70 ± 0.07 1.10 ± 0.26 3.00 ± 0.47 5.50 ± 0.30 7.60 ± 0.30 9.90 ± 0.43
4f 1.00 ± 0.18 2.00 ± 0.45 3.00 ± 0.15 5.00 ± 0.55 4.00 ± 0.50 7.10 ± 0.36 9.50 ± 0.26 12.0 ± 0.40
4g 1.00 ± 0.09 2.50 ± 0.35 3.00 ± 0.16 5.50 ± 0.50 a a 1.10 ± 0.20 2.00 ± 0.30
4h 1.00 ± 0.12 2.00 ± 0.17 3.00 ± 0.15 4.00 ± 0.45 1.10 ± 0.22 1.90 ± 0.40 3.00 ± 0.26 5.00 ± 0.50

All values are mean ± S.D.

a: No Inhibition Zone

Fig 12. Box plot of substituted dihyropyrimidinones (4a-4h) against Erwina cartovora.

Fig 12

Fig 15. Antibacterial activity of substituted dihyropyrimidinones (4a-4h) against Xanthomonas citri.

Fig 15

Fig 13. Antibacterial activity of substituted dihyropyrimidinones (4a-4h) against Erwina cartovora.

Fig 13

Fig 14. Box plot of substituted dihyropyrimidinones (4a-4h) against Xanthomonas citri.

Fig 14

Characterization data of selected compounds

Methyl 4-(2-hydroxyphenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4a): 1H NMR (400 MHz, DMSO-d6): δ 1.75 (s, 3H, CH3); 3.71 (s, 3H, COOCH3); 4.51 (s, 1H, OH); 6.73–7.19 (m, J = 8 Hz, 4H, Ar-H); 7.46 (s, 1H, NH); 7.69 (s, 1H, NH)

Methyl 6-(4-methoxyphenyl)-4-methyl-2-oxo-1, 2-dihydropyrimidine-5-carboxylate (4b): 1H NMR (400 MHz, DMSO-d6): δ 2.25 (s, 3H, CH3); 3.72 (s, 3H, Ar-OCH3); 3.51 (s, 3H, COOCH3); 6.57–7.66 (m, J = 8 Hz, 4H, Ar-H); 5.11 (s, 1H, NH); 9.16 (s, 1H, NH)

Methyl 4-(3,4-dimethoxyphenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4c): 1H NMR (400 MHz, DMSO-d6): δ 2.51 (s, 3H, CH3); 3.82 (s, 3H, Ar-OCH3); 3.86 (s, 3H, Ar-OCH3); 7.13–7.16 (d, J = 12 Hz, 1H, Ar-H); 7.37–7.38 (d, J = 4 Hz, 1H, Ar-H); 7.53–7.55 (m, J = 8 Hz, 1H, Ar-H); 5.48 (s, 1H, NH); 9.83 (s, 1H, NH)

Methyl 6-(4-chlorophenyl)-4-methyl-2-oxo-1,2-dihydropyrimidine-5-carboxylate (4d): IR (νmax cm-1) (neat): 3415.3 (NH), 3325.7 (NH), 1680.5 (C = O), 1591.5 (C = C, aromatic), 761.0 (C-Cl)

Methyl 6-(4-bromophenyl)-4-methyl-2-oxo-1,2-dihydropyrimidine-5-carboxylate (4e): IR (νmax cm-1) (neat): 3436.6 (NH), 3307.5 (NH), 1696.2 (C = O), 1587.8 (C = C, aromatic), 811.7 (C-Br)

Methyl 6-(3-hydroxyphenyl)-4-methyl-2-oxo-1,2-dihydropyrimidine-5-carboxylate (4f): IR (νmax cm-1) (neat): 3227.7 (NH), 3106.4 (NH), 3372.4 (OH), 1714.0 (C = O), 1487.9 (C = C, aromatic)

Methyl 6-(2-chlorophenyl)-4-methyl-2-oxo-1,2-dihydropyrimidine-5-carboxylate (4g): 1H NMR (400 MHz, DMSO-d6): δ 2.31 (s, 3H, CH3); 3.46 (s, 3H, COOCH3); 7.20–7.36 (m, J = 8 Hz, 4H, Ar-H); 5.65 (s, 1H, NH); 9.27 (s, 1H, NH)

Methyl 4-methyl-2-oxo-6-(p-tolyl)-1,2-dihydropyrimidine-5-carboxylate (4h): IR (νmax cm-1) (neat): 3484.4 (NH), 3335.7 (NH), 1740.5 (C = O), 1651.7 (C = C, aromatic)

Conclusions

We have reported a facile one-pot three component synthesis of substituted dihydropyrimidinones derivatives (4a-4h) by condensation of substituted aldehyde, methyl acetoacetate and urea at room temperature in presence of Cocos nucifera L. juice, Solanum lycopersicum L. juice and Citrus limetta juice in excellent yields. The current procedure offers many advantages such as simple and efficient catalytic system, simple work-up, no use of hazardous solvents, cheap and products were obtained in good to excellent yields. Moreover, all products were obtained through simple filtration with no need for column chromatography, which reduces the waste as well as environmental pollution. All synthesized compounds (4a-4h) were also evaluated for their bioevaluation in terms of herbicidal activity against Raphanus sativus L. (Radish) seeds, antifungal activity against Rhizoctonia solani &Colletotrichum gloeosporioides and antibacterial activity against Erwinia cartovora and Xanthomonas citri. Based on activity data, it can be concluded that some of synthesized compounds exhibited good activity due to substitution of chloro, hydroxy and methoxy substitution on phenyl ring. We also conclude that current protocol will provide great utility in the synthesis of other heterocyclic compounds in the near future.

Supporting information

S1 Fig

(DOCX)

S2 Fig

(DOCX)

S3 Fig

(DOCX)

S4 Fig

(DOCX)

S5 Fig

(DOCX)

S6 Fig

(DOCX)

S7 Fig

(DOCX)

S8 Fig

(DOCX)

S9 Fig

(DOCX)

S10 Fig

(DOCX)

S11 Fig

(DOCX)

S12 Fig

(DOCX)

S13 Fig

(DOCX)

S14 Fig

(DOCX)

S15 Fig

(DOCX)

S16 Fig

(DOCX)

S17 Fig

(DOCX)

S18 Fig

(DOCX)

S19 Fig

(DOCX)

S20 Fig

(DOCX)

S21 Fig

(DOCX)

S22 Fig

(DOCX)

S23 Fig

(DOCX)

S1 Table

(DOCX)

S2 Table

(DOCX)

S3 Table

(DOCX)

Graphical abstract

(TIF)

Acknowledgments

The authors are thankful to the Department of Chemistry, Chaudhary Charan Singh Haryana Agricultural University, Hisar for providing the necessary facilities. Authors are also thankful to SAIF, Punjab University Chandigarh, for providing analytical facilities for characterization of compounds.

Data Availability

All relevant data are within the paper and its supporting information files.

Funding Statement

Authors received no specific funding for this study.

References

  • 1.Rovnyak GC, Kimball SD, Beyer B, Cucinotta G, DiMarco JD, Gougoutas J, et al. Calcium entry blockers and activators: conformational and structural determinants of dihydropyrimidine calcium channel modulators. J. Med. Chem., 1995. 38(1):119–129. [DOI] [PubMed] [Google Scholar]
  • 2.Atwal KS, Rovnyak GC, Kimball SD, Floyd DM, Moreland S, Swanson BN, et al. Dihydropyrimidine calcium channel blockers. II. 3-Substituted-4-aryl-1, 4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines. J. Med. Chem., 1990. 33(9):2629–2635. [DOI] [PubMed] [Google Scholar]
  • 3.Cho H, Ueda M, Shima K, Mizuno A, Hayashimatsu M, Ohnaka Y, et al. Dihydropyrimidines: novel calcium antagonists with potent and long-lasting vasodilative and anti-hypertensive activity. J. Med. Chem., 1989. 32(10):2399–2406. [DOI] [PubMed] [Google Scholar]
  • 4.Patil S, Jadhav SD, Deshmukh MB. Natural acid catalyzed multi-component reactions as a green approach. Arch. Apll. Sci. Res., 2011. 3(1):203–208. [Google Scholar]
  • 5.Tamuli KJ, Dutta D, Nath S, Bordoloi M. A Greener and Facile Synthesis of Imidazole and Dihydropyrimidine Derivatives under Solvent‐Free Condition Using Nature‐Derived Catalyst. Chemistry Select. 2017. 2(26):7787–7791. [Google Scholar]
  • 6.Pramanik T, Pathan AH, Gupta R, Singh J, Singh S. Exploring the utility of fruit juices as green medium for Biginelli reaction. Res. J. Pharm. Bio. Chem. Sci. 2013. 5(5):444–449. [Google Scholar]
  • 7.Pal R. Fruit juice; A natural, green and biocatalyst system in organic synthesis. Open J. Org. Chem. 2013. 1(4);47–56. [Google Scholar]
  • 8.Roe RM, Burton JD, Kuhr RJ, editors. Herbicide activity: toxicology, biochemistry and molecular biology. IOS Press; 1997. [Google Scholar]
  • 9.Grove RK, Moore JD. Toximetric studies of fungicides against brown rot organism Sclerotina fruticola. Phytopathology. 1962. 52:876–880. [Google Scholar]
  • 10.Thornberry HH. A paper-disk plate method for the quantitative evaluation of fungicides and bactericides. Phytopathology. 1950. 40(5). [Google Scholar]
  • 11.Fonseca AM, Monte FJ, Maria da Conceição F, de Mattos MC, Cordell GA, Braz-Filho R, et al. Coconut water (Cocos nucifera L.)—A new biocatalyst system for organic synthesis. J. Mol. Catal. B Enzym. 2009. 57(1–4):78–82. [Google Scholar]
  • 12.Zia M, Gul S, Akhtar J, Ul Haq I, Abbasi BH, Hussain A, et al. Green synthesis of silver nanoparticles from grape and tomato juices and evaluation of biological activities. IET nanobiotechnology. 2016. 11(2):193–199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Jamil NE, Jabeen R, Khan MU, Riaz MU, Naeem TA, Khan AQ, et al. Quantitative assessment of juice content, citric acid and sugar content in oranges, sweet lime, lemon and grapes available in fresh fruit market of quetta city. Int. J. Basic appl. Sci. 2015. 15(1):157301–6464. [Google Scholar]
  • 14.Sharma N, Sharma UK., Kumar R, Richa, Sinha AK. Green and recyclable glycine nitrate (GlyNO3) ionic liquid triggered multicomponent Biginelli reaction for the efficient synthesis of dihydropyrimidinones. RSC Adv. 2012, 28;1–4. [Google Scholar]
  • 15.Paraskar AS, Dewkar GK, Sudalai A. Cu (OTf) 2: a reusable catalyst for high-yield synthesis of 3, 4-dihydropyrimidin-2 (1H)-ones. Tetrahedron Lett., 2003. 44(16):3305–3308. [Google Scholar]
  • 16.Nazeruddin GM, Shaikh YI. Tamarind juice catalyzed one pot synthesis of dihydropyrimidinone and thione under ultrasound irradiation at ambient conditions: A green approach. Der Pharmacia Sinica., 2014. 5(6):64–68. [Google Scholar]
  • 17.Xue S, Shen YC, Li YL, Shen XM, Guo QX. Synthesis of 4‐aryl‐3, 4‐dihydropyrimidinones using microwave‐assisted solventless Biginelli reaction. Chin. J. Chem., 2002. 20(4):385–389. [Google Scholar]
  • 18.Ma JJ, Zang XH, Zhou X, Wang C, Li JC, Li Q. One-pot synthesis of 3, 4-dihydropyrimidin-2 (1H)-ones catalyzed by acidic ionic liquid. [Google Scholar]
  • 19.Jin T, Zhang S, Li T. p-toluenesulfonic acid-catalyzed efficient synthesis of dihydropyrimidines: improved high yielding protocol for the Biginelli reaction. Syn. Comm., 2002. 32(12):1847–51. [Google Scholar]
  • 20.Pasha MA, Swamy NR, Jayashankara VP. One pot synthesis of 3, 4-dihydropyrimidin- 2 (1H)—ones/- thiones catalyzed by zinc chloride: An improved procedure for the Biginelli reaction using microwaves under solvent free conditions. Indian J. Chem., Section B: Organic Chemistry Including Medicinal Chemistry. 2005;44(4):823–826. [Google Scholar]
  • 21.Kundu SK, Majee A, Hajra A. Environmentally benign aqueous zinc tetrafluoroborate-catalyzed one-pot Biginelli condensation at room temperature. [Google Scholar]
  • 22.Aridoss G, Jeong YT. A convenient one-pot Biginelli reaction catalyzed by Y (OAc)3: an improved protocol for the synthesis of 3, 4-dihydropyrimidin-2 (1H)-ones and their sulfur analogues. Bull. Korean Chem. Soc., 2010. 31(4):863–868. [Google Scholar]
  • 23.Boumoud T, Boumoud B, Rhouati S, Belfaitah A, Debache A, Mosset P. A Novel Catalyst for One-Pot Synthesis of Substituted 3, 4-Dihydropyrimidin-2-(1H)-ones via Biginelli Reaction Under Solvent-Free Conditions. Acta Chim. Slov., 2008. 55(3). [Google Scholar]
  • 24.Gangadasu B, Narender P, Raju B, Rao VJ. Calcium chloride catalyzed three component, one-pot condensation reaction: An efficient synthesis of 3, 4-dihydropyrimidin-2 (1H)-ones. [Google Scholar]
  • 25.Fu NY, Pang ML, Yuan YF, Wang JT. Indium (III) tribromide: An excellent catalyst for Biginelli reaction. Chinese Chem. Lett., 2002. 13(10):921–922. [Google Scholar]
  • 26.Boumoud T, Boumoud B, Rhouati S, Belfaitah A, Debache A, Mosset P. An efficient and recycling catalyst for the one-pot three-component synthesis of substituted 3, 4-dihydropyrimidin-2 (1H)-ones. E. J. Chem., 2008. 5. [Google Scholar]
  • 27.Deshmukh MB, Anbhule PV, Jadhav SD, Mali AR, Jagtap SS, Deshmukh SA. An efficient, simple, one pot synthesis of dihydropyrimidine-2 (1H) ones using phosphorus pentoxide. [Google Scholar]
  • 28.Ramu E, Kotra V, Bansal N, Varala R, Adapa SR. Green approach for the efficient synthesis of Biginelli compounds promoted by citric acid under solvent-free conditions. Rasayan Journal of Chem., 2008. 1(1):188–194. [Google Scholar]

Decision Letter 0

A Ganesan

7 Jul 2020

PONE-D-20-15280

One-Pot Three Component Synthesis of Substituted Dihydropyrimidinones Using Fruit Juices as Biocatalyst and their Biological Studies

PLOS ONE

Dear Dr. Gulati,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The manuscript was reviewed by three experts who have differing opinions, including one who recommended rejection. The revised manuscript should address all the comments and feedback provided by the reviewers. To summarise, here are the key points:

  • Simplify the abstract

  • Cite appropriate scientific literature including the examples recommended by the reviewers

  • Correct solvent free to ‘under aqueous conditions’

  • Carry out quantitative measurement of natural acids and proteins as requested by reviewer 1

  • Discuss the nature of the catalyst- ascorbic acid, other acids, metal ions etc.

  • Follow the literature precedents for discussion on the mechanism

  • Write clear experimental procedures to enable reproducibility by others

  • Provide detailed characterization of compounds including copies of NMR spectra to confirm compound purity

Please submit your revised manuscript by 6 August. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

A Ganesan

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.  

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following:

  • The name of the colleague or the details of the professional service that edited your manuscript

  • A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)

  • A clean copy of the edited manuscript (uploaded as the new *manuscript* file)

3. We noticed you have some minor occurrence of overlapping text with previous publications, which needs to be addressed. In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed.

4. Please amend your Financial disclosure statement to declare sources of funding, or state that the authors received no specific funding.

Thank you for stating the following in the Acknowledgments Section of your manuscript:

"Financial assistance from Department of Science and Technology (DST), New Delhi, India is gratefully acknowledged."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"NO"

5. We note that this submission includes NMR spectroscopy data. We would recommend that you include the following information in your methods section or as Supporting Information files:

1) The make/source of the NMR instrument used in your study, as well as the magnetic field strength. For each individual experiment, please also list: the nucleus being measured; the sample concentration; the solvent in which the sample is dissolved and if solvent signal suppression was used; the reference standard and the temperature.

2) A list of the chemical shifts for all compounds characterised by NMR spectroscopy, specifying, where relevant: the chemical shift (δ), the multiplicity and the coupling constants (in Hz), for the appropriate nuclei used for assignment.

3)The full integrated NMR spectrum, clearly labelled with the compound name and chemical structure.

We also strongly encourage authors to provide primary NMR data files, in particular for new compounds which have not been characterised in the existing literature. Authors should provide the acquisition data, FID files and processing parameters for each experiment, clearly labelled with the compound name and identifier, as well as a structure file for each provided dataset. See our list of recommended repositories here: https://journals.plos.org/plosone/s/recommended-repositories

6. We note that Graphical Abstract in your submission contain copyrighted images. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

6. 1.         You may seek permission from the original copyright holder of Graphical Abstract to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. 

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

6.2.    If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

7. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Substituted Dihydropyrimidinones are very well known from high biological activity. Common synthetic method leading to target product is based on one-pot three - components reaction. Several aspects of this reaction were already discussed within literature. The authors used as a solvent for reaction fruit juices viz. Cocos nucifera L., Solanum lycopersicum L., Citrus limetta. Model experiments on 4-hydroxy-3-methoxybenzaldehyde, methyl acetoacetate and urea were performed in Cocos nucifera L. juice. The juices were used as prepared and not characterized. The protein contents, the amounts of natural acids was not determined what makes this procedure completely unrepeatable. Although the authors claims in graphical abstract that natural acids participate in reaction that was not validated.

The results of model experiments showed in Table 1 and 2 are confusing to readers since respective experimental procedures are entirely different. It seems to reader that the amount of juice was changed from 1 to 2.5 mL (Table 1) and rom 4 to 10 ml (Table 2). This is just the dilution effect on the reaction course not catalytic effect. The product which should be obtained in reaction is missed in experimental part. The synthetic procedures are full of mistakes and misunderstandings. In method B on page 33 reaction mixture was stirred at room temperature and then cooled to room temperature. Compounds provided in Table 3 were characterized by melting points and 1H NMR what is far away from Journal requirements. The purity of all substances was not determined what do not fulfill requirements of the Journal. The catalytic effect of juices was only postulated and was not verified. The contents of Table 4 is difficult to understand since the experimental procedure is not included in manuscript body. The possible mechanism of reaction discussed in Scheme 2 should be based on sole literature data not speculations. Biological dates were collected for compounds of undefined purity.

Reviewer #2: Authors have described a new and facile one-pot three component synthetic protocol for substituted dihydropyrimidinones derivatives via reaction of equimolar substituted aldehydes, methyl acetoacetate and urea in presence of nature derived catalyst viz. Cocos nucifera L. juice, Solanum lycopersicum L. juice and Citrus limetta juice, commonly known as coconut juice, tomato juice and musambi juice, respectively, at room temperature.

This reviewer doesn’t have much in terms of criticism for the described work which has been very well explored in the literature before; one of the most explored reaction under dozens of reaction conditions.

The major comment at the outset is to decrease the verbose descriptions in the abstract; it reads more like an introduction and experimental presently; no need to mention TLC, or characterization details, mmol scale and in fact with proper referencing, they can avoid lots of duplication of data on known compounds. Secondly, authors have described properly in conclusion but to say that it is a solvent-free reaction is not correct as juices are mostly water. So, aqueous media is the correct description.

I that context, I think it would be prudent to have some quality references while describing the reaction as most of the citations are poor quality and not from original works. As an example, this reviewer could easily find 2 examples for solvent-free and aqueous medium reaction, respectively on the title compounds, as shown below:

Microwave-Assisted High-Speed Parallel Synthesis of 4-Aryl-Dihydro-pyrimidin-2(1H)-ones using a Solventless Biginelli Condensation Protocol. Synthesis, 1799-1803 (1999)

and

Biginelli Reaction in Aqueous Medium: A Greener and Sustainable Approach to Substituted 3,4-Dihydropyrimidin-2(1H)-ones. Tetrahedron Lett., 48, 7343 (2007). Similar types of citations should be offered in the introduction section and like most of the paper, description need to be curtailed enormously. Authors have not cited a relevant paper that describes the utility of juices, “Exploring the utility of fruit juices as green medium for Biginelli reaction”, December 2013, Research Journal of Pharmaceutical, Biological and Chemical Sciences 5(5) :444-449 and related papers by TANAY PRAMANIK, SIMARJIT KAUR PADAN on this topic.

Reviewer #3: The authors here display an important study that used some natural juices as catalysts to attain Bignilli Reaction

and study the Herbicidal activity and antibacterial activity of the obtained compounds

The results show that Cocos nucifera L. juice is the best catalyst for the used time 10 min.

But I am surprising that author put in graphical abstract some acid that may be mean the component of juices

this is not logic if the catalytic activity of Cocos nucifera L. juice due to Ascorbic acid, therefor the results of ascorbic acid should be put in table 2 which present in the following ref.

Ascorbic acid-Catalyzed One-Pot Three-Component Biginelli Reaction: A Practical and Green Approach towards Synthesis of 3,4-dihydropyrimidin- 2(1H)-ones/thiones

Journal Name: Letters in Organic Chemistry

Volume 10 , Issue 7 , 2013

But Cocos nucifera L. juice contain many sugers, many vitamins includs Vit. C (Ascorbic acid) and many metal ion that may be make a synergistic action that give this catalytic activity.

Therefore authors should remove the acids that present in Graphical Abstract.

also, authors should submit NMR Charts for the synthesized compounds to ensure the purity.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: Tamer S. Saleh

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Sep 15;15(9):e0238092. doi: 10.1371/journal.pone.0238092.r002

Author response to Decision Letter 0


10 Jul 2020

R/Sir all the suggestions according to reviewer comments incorporated successfully in revised manuscript. Thanks to editorial staff and reviewer their timely support and necessary suggestions for making this manuscript fruitful. All suggestions were shown in manuscript by track change mode.

Comments from the Editors and Reviewers:

Comments to the Author

Simplify the abstract

Answer to Reviewer:

� Authors simplify the abstract according to reviewer suggestions in revised manuscript.

Comments to the Author

Cite appropriate scientific literature including the examples recommended by the reviewers

Answer to Reviewer:

� Authors cited the appropriate scientific literature in the manuscript. For e.g.

1. Patil S, Jadhav SD, Deshmukh MB. Natural acid catalyzed multi-component reactions as a green approach. Arch. Apll. Sci. Res., 2011 3(1):203-208.

2. Tamuli KJ, Dutta D, Nath S, Bordoloi M. A Greener and Facile Synthesis of Imidazole and Dihydropyrimidine Derivatives under Solvent‐Free Condition Using Nature‐Derived Catalyst. Chemistry Select. 2017 2(26):7787-7791.

3. Fonseca AM, Monte FJ, Maria da Conceição F, de Mattos MC, Cordell GA, Braz-Filho R, Lemos TL. Coconut water (Cocos nucifera L.)—A new biocatalyst system for organic synthesis. J. Mol. Catal. B Enzym. 2009 57(1-4):78-82.

4. Nazeruddin GM, Shaikh YI. Tamarind juice catalyzed one pot synthesis of dihydropyrimidinone and thione under ultrasound irradiation at ambient conditions: A green approach. Der Pharmacia Sinica., 2014 5(6):64-68.

5. Ramu E, Kotra V, Bansal N, Varala R, Adapa SR. Green approach for the efficient synthesis of Biginelli compounds promoted by citric acid under solvent-free conditions. Rasayan Journal of Chem., 2008 1(1):188-194.

Comments to the Author

Correct solvent free to ‘under aqueous conditions’

Answer to Reviewer:

� Authors replaced solvent-free to ‘under aqueous conditions’ in revised manuscript.

Comments to the Author

Carry out quantitative measurement of natural acids and proteins as requested by reviewer 1

Answer to Reviewer:

� Authors in their experiment not quantify natural acids and proteins.

Comments to the Author

Discuss the nature of the catalyst- ascorbic acid, other acids, metal ions etc.

Answer to Reviewer:

� Authors used nature derived catalyst viz. Cocos nucifera L. juice, Solanum lycopersicum L. juice and Citrus limetta juice in their study. All these catalyst contain various organic acids mainly ascorbic acid, citric acid and malic acid etc. All these acids are weak organic acid. Ascorbic acid is an organic compounds called hexuronic acid and it dissolves well in water to give mildly acidic solutions. It is mild reducing agent.

Comments to the Author

Follow the literature precedents for discussion on the mechanism

Answer to Reviewer:

� Authors cited the literature for discussion on the mechanism in revised manuscript.

Comments to the Author

Write clear experimental procedures to enable reproducibility by others

Answer to Reviewer:

� Authors improved the experimental procedure in revised manuscript. Now the experimental procedure becomes clearer.

Comments to the Author

Provide detailed characterization of compounds including copies of NMR spectra to confirm compound purity

Answer to Reviewer:

� Authors provided detailed characterization (IHNMR and FTIR) of some selected compounds to confirm compound purity.

� Compounds name and structure also provided in NMR and FTIR chart file.

� Authors revised the manuscript according to PLOS ONE style.

� Authors deleted the funding information in the Acknowledgments section in revised manuscript.

� Authors revised the graphical abstract according to reviewer suggestions.

� Authors successfully added the details of colleague who edited the manuscript in revised manuscript.

� Authors successfully added the financial disclosure statement “Authors receive no specific funding” in revised manuscript.

� Authors successfully deleted the copy right images from the graphical abstract and revised the graphical abstract according to reviewer suggestions in revised manuscript.

� Authors successfully added Data availability statement in revised manuscript.

� Authors successfully uploaded minimal underlying data set as either Supporting Information files in revised manuscript.

� Authors thoroughly copyedit the manuscript for language usage, spelling, and grammar.

� In manuscript all the graph made by OriginPro 8 software and standard deviation was also included in graphical representation to make manuscript more scientifically.

� All the structure in manuscript made by using ChemDraw Ultra 12.0 software.

� Manuscript is now accordance to PLOS ONE style.

� Thanks to the editorial board and reviewers for necessary suggestions regarding the manuscript.

Attachment

Submitted filename: Response file.docx

Decision Letter 1

A Ganesan

6 Aug 2020

PONE-D-20-15280R1

One-Pot Three Component Synthesis of Substituted Dihydropyrimidinones Using Fruit Juices as Biocatalyst and their Biological Studies

PLOS ONE

Dear Dr. Gulati

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

One reviewer has commented on the revised manuscript, and has suggested some additional changes with regards to the references. These recommendations should be followed.

==============================

Please submit your revised manuscript by 15 August 2020. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

A Ganesan

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Although it has improved fair bit but the suggested quality and original references in the introduction section have not been incorporated and the last three references now added are of poor quality. I reproduce what I suggested originally, again:

As an example, this reviewer could easily find 2 examples for solvent-free and aqueous medium reaction, respectively on the title compounds, as shown below:

Microwave-Assisted High-Speed Parallel Synthesis of 4-Aryl-Dihydro-pyrimidin-2(1H)-ones using a Solventless Biginelli Condensation Protocol. Synthesis, 1799-1803 (1999)

and

Biginelli Reaction in Aqueous Medium: A Greener and Sustainable Approach to Substituted 3,4-Dihydropyrimidin-2(1H)-ones. Tetrahedron Lett., 48, 7343 (2007). Similar types of citations should be offered in the introduction section and like most of the paper, description need to be curtailed enormously. Authors have not cited a relevant paper either that describes the utility of juices, “Exploring the utility of fruit juices as green medium for Biginelli reaction”, December 2013, Research Journal of Pharmaceutical, Biological and Chemical Sciences 5(5) :444-449 and related papers by TANAY PRAMANIK, SIMARJIT KAUR PADAN on this topic.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Sep 15;15(9):e0238092. doi: 10.1371/journal.pone.0238092.r004

Author response to Decision Letter 1


6 Aug 2020

R/Sir all the suggestions according to reviewer comments incorporated successfully in revised (R2 [PONE-D-20-15280R1]) manuscript. Thanks to editorial staff and reviewer for their timely support and necessary suggestions for making revised manuscript more fruitful. All suggestions were shown in manuscript by track change mode. Respond to reviewer were shown in Blue colour.

Comments from the Editors and Reviewers:

Comments to the Author

Simplify the abstract

Answer to Reviewer:

� Authors simplify the abstract according to reviewer suggestions in revised manuscript.

Comments to the Author

Cite appropriate scientific literature including the examples recommended by the reviewers

Answer to Reviewer:

� Authors cited the appropriate scientific literature in the manuscript. For e.g.

1. Patil S, Jadhav SD, Deshmukh MB. Natural acid catalyzed multi-component reactions as a green approach. Arch. Apll. Sci. Res., 2011 3(1):203-208.

2. Tamuli KJ, Dutta D, Nath S, Bordoloi M. A Greener and Facile Synthesis of Imidazole and Dihydropyrimidine Derivatives under Solvent‐Free Condition Using Nature‐Derived Catalyst. Chemistry Select. 2017 2(26):7787-7791.

3. Fonseca AM, Monte FJ, Maria da Conceição F, de Mattos MC, Cordell GA, Braz-Filho R, Lemos TL. Coconut water (Cocos nucifera L.)—A new biocatalyst system for organic synthesis. J. Mol. Catal. B Enzym. 2009 57(1-4):78-82.

4. Nazeruddin GM, Shaikh YI. Tamarind juice catalyzed one pot synthesis of dihydropyrimidinone and thione under ultrasound irradiation at ambient conditions: A green approach. Der Pharmacia Sinica., 2014 5(6):64-68.

5. Ramu E, Kotra V, Bansal N, Varala R, Adapa SR. Green approach for the efficient synthesis of Biginelli compounds promoted by citric acid under solvent-free conditions. Rasayan Journal of Chem., 2008 1(1):188-194.

Comments to the Author

Correct solvent free to ‘under aqueous conditions’

Answer to Reviewer:

� Authors replaced solvent-free to ‘under aqueous conditions’ in revised manuscript.

Comments to the Author

Carry out quantitative measurement of natural acids and proteins as requested by reviewer 1

Answer to Reviewer:

� Authors in their experiment not quantify natural acids and proteins.

Comments to the Author

Discuss the nature of the catalyst- ascorbic acid, other acids, metal ions etc.

Answer to Reviewer:

� Authors used nature derived catalyst viz. Cocos nucifera L. juice, Solanum lycopersicum L. juice and Citrus limetta juice in their study. All these catalyst contain various organic acids mainly ascorbic acid, citric acid and malic acid etc. All these acids are weak organic acid. Ascorbic acid is an organic compounds called hexuronic acid and it dissolves well in water to give mildly acidic solutions. It is mild reducing agent.

Comments to the Author

Follow the literature precedents for discussion on the mechanism

Answer to Reviewer:

� Authors cited the literature for discussion on the mechanism in revised manuscript.

Comments to the Author

Write clear experimental procedures to enable reproducibility by others

Answer to Reviewer:

� Authors improved the experimental procedure in revised manuscript. Now the experimental procedure becomes clearer.

Comments to the Author

Provide detailed characterization of compounds including copies of NMR spectra to confirm compound purity

Answer to Reviewer:

� Authors provided detailed characterization (IHNMR and FTIR) of some selected compounds to confirm compound purity.

� Compounds name and structure also provided in NMR and FTIR chart file.

� Authors revised the manuscript according to PLOS ONE style.

� Authors deleted the funding information in the Acknowledgments section in revised manuscript.

� Authors revised the graphical abstract according to reviewer suggestions.

� Authors successfully added the details of colleague who edited the manuscript in revised manuscript.

� Authors successfully added the financial disclosure statement “Authors receive no specific funding” in revised manuscript.

� Authors successfully deleted the copy right images from the graphical abstract and revised the graphical abstract according to reviewer suggestions in revised manuscript.

� Authors successfully added Data availability statement in revised manuscript.

� Authors successfully uploaded minimal underlying data set as either Supporting Information files in revised manuscript.

� Authors thoroughly copyedit the manuscript for language usage, spelling, and grammar.

� In manuscript all the graph made by OriginPro 8 software and standard deviation was also included in graphical representation to make manuscript more scientifically.

� All the structure in manuscript made by using ChemDraw Ultra 12.0 software.

� Manuscript is now accordance to PLOS ONE style.

� Thanks to the editorial board and reviewers for necessary suggestions regarding the manuscript.

Answer to Reviewer Regarding [PONE-D-20-15280R1]:

� In revised manuscript author had cited relevant papers that explain the utility of fruit juices in organic synthesis in introduction part of manuscript and detail of references are given below:

� Pramanik T, Pathan AH, Gupta R, Singh J, Singh S. Exploring the utility of fruit juices as green medium for Biginelli reaction. Res. J. Pharm. Bio. Chem. Sci. 2013 5(5):444-449.

� Pal R. Fruit juice; A natural, green and biocatalyst system in organic synthesis. Open J. Org. Chem. 2013 1(4);47-56.

� Authors also deleted the poor quality references from the manuscript. Quality reference which explain the mechanism of reaction was include in revised manuscript and details reference given as below:

� Sharma N, Sharma UK., Kumar R, Richa, Sinha AK. Green and recyclable glycine nitrate (GlyNO3) ionic liquid triggered multicomponent Biginelli reaction for the efficient synthesis of dihydropyrimidinones. RSC Adv. 2012, 28;1-4.

� Authors feel that revised manuscript acceptable for publication and authors declared that there is no conflict of interest regarding publication of this paper.

� The revised manuscript is technically sound, scientifically written. Experiments related to biological activity were performed in triplicate and conclusion is well written based on data presented in manuscript.

� Statistical analysis (Standard deviation) mentioned in table and graph for making revised manuscript more informative.

� All relevant data are within the paper and its supporting information files. Authors made all data underlying the findings in their manuscript fully available.

� Authors presented the manuscript in intelligible fashion and written in standard English language.

� Financial disclosure statement was also given in cover letter. Authors received no specific funding for this study. The funder has no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.

� All the figures in revised manuscript meet PLOS requirements, according to Preflight Analysis and Conversion Engine (PACE).

� Revised manuscript fully meets PLOS ONE’s publication criteria.

� Thanks to the editorial board and reviewers for necessary suggestions regarding the manuscript. Please consider all the points mentioned above and if reviewer required any more revision then inform by email.

Attachment

Submitted filename: Response file.docx

Decision Letter 2

A Ganesan

11 Aug 2020

One-Pot Three Component Synthesis of Substituted Dihydropyrimidinones Using Fruit Juices as Biocatalyst and their Biological Studies

PONE-D-20-15280R2

Dear Dr. Gulati,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

A Ganesan

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig

    (DOCX)

    S2 Fig

    (DOCX)

    S3 Fig

    (DOCX)

    S4 Fig

    (DOCX)

    S5 Fig

    (DOCX)

    S6 Fig

    (DOCX)

    S7 Fig

    (DOCX)

    S8 Fig

    (DOCX)

    S9 Fig

    (DOCX)

    S10 Fig

    (DOCX)

    S11 Fig

    (DOCX)

    S12 Fig

    (DOCX)

    S13 Fig

    (DOCX)

    S14 Fig

    (DOCX)

    S15 Fig

    (DOCX)

    S16 Fig

    (DOCX)

    S17 Fig

    (DOCX)

    S18 Fig

    (DOCX)

    S19 Fig

    (DOCX)

    S20 Fig

    (DOCX)

    S21 Fig

    (DOCX)

    S22 Fig

    (DOCX)

    S23 Fig

    (DOCX)

    S1 Table

    (DOCX)

    S2 Table

    (DOCX)

    S3 Table

    (DOCX)

    Graphical abstract

    (TIF)

    Attachment

    Submitted filename: Response file.docx

    Attachment

    Submitted filename: Response file.docx

    Data Availability Statement

    All relevant data are within the paper and its supporting information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES